|
1
|
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.
|
N Engl J Med
|
2011
|
18.99
|
|
2
|
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
|
Sci Transl Med
|
2011
|
12.58
|
|
3
|
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
|
Mol Genet Metab
|
2003
|
5.27
|
|
4
|
Survival of acute myeloid leukemia cells requires PI3 kinase activation.
|
Blood
|
2003
|
2.93
|
|
5
|
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
|
Blood
|
2013
|
2.91
|
|
6
|
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.
|
N Engl J Med
|
2015
|
2.77
|
|
7
|
Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.
|
Br J Haematol
|
2007
|
1.90
|
|
8
|
Utility of FDG-PET scanning in lymphoma by WHO classification.
|
Blood
|
2003
|
1.69
|
|
9
|
Coexisting follicular and mantle cell lymphoma with each having an in situ component: A novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma.
|
Am J Clin Pathol
|
2010
|
1.65
|
|
10
|
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.
|
Clin Cancer Res
|
2008
|
1.48
|
|
11
|
Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
|
Am J Hematol
|
2005
|
1.43
|
|
12
|
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
|
Clin Cancer Res
|
2009
|
1.42
|
|
13
|
Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
|
Am J Hematol
|
2002
|
1.37
|
|
14
|
Erythropoietin gene therapy leads to autoimmune anemia in macaques.
|
Blood
|
2003
|
1.30
|
|
15
|
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
|
Haematologica
|
2011
|
1.22
|
|
16
|
Guidance for fluorescence in situ hybridization testing in hematologic disorders.
|
J Mol Diagn
|
2007
|
1.20
|
|
17
|
Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity.
|
J Virol
|
2002
|
1.20
|
|
18
|
The evolution of molecular genetic pathology: advancing 20th-century diagnostic methods into potent tools for the new millennium.
|
J Mol Diagn
|
2008
|
1.11
|
|
19
|
Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice.
|
J Mol Diagn
|
2003
|
1.10
|
|
20
|
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
|
Blood
|
2014
|
1.10
|
|
21
|
A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics.
|
Am J Clin Pathol
|
2011
|
1.04
|
|
22
|
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.
|
J Pediatr
|
2009
|
1.01
|
|
23
|
Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
|
Cytometry B Clin Cytom
|
2005
|
0.96
|
|
24
|
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management.
|
Cancer Biol Ther
|
2007
|
0.94
|
|
25
|
Intravascular large B-cell lymphoma: a mimicker of many maladies and a difficult and often delayed diagnosis.
|
J Clin Oncol
|
2010
|
0.94
|
|
26
|
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
|
Am J Hematol
|
2008
|
0.93
|
|
27
|
IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue.
|
Hum Pathol
|
2009
|
0.90
|
|
28
|
Isolated bowel relapse in acute promyelocytic leukemia: an unusual site of extramedullary recurrence.
|
J Clin Oncol
|
2010
|
0.87
|
|
29
|
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
|
Haematologica
|
2014
|
0.86
|
|
30
|
Myelodysplastic syndromes. Contemporary biologic concepts and emerging diagnostic approaches.
|
Am J Clin Pathol
|
2003
|
0.85
|
|
31
|
Recurrence of nodal diffuse large B-cell lymphoma as intravascular large B-cell lymphoma: is an intravascular component at initial diagnosis predictive?
|
Arch Pathol Lab Med
|
2005
|
0.85
|
|
32
|
Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?
|
Am J Clin Pathol
|
2008
|
0.85
|
|
33
|
Lineage ambiguity, infidelity, and promiscuity in immunophenotypically complex acute leukemias: genetic and morphologic correlates.
|
Am J Clin Pathol
|
2007
|
0.84
|
|
34
|
Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.
|
Mol Diagn Ther
|
2012
|
0.82
|
|
35
|
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
|
Am J Hematol
|
2014
|
0.82
|
|
36
|
CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
|
Am J Hematol
|
2002
|
0.81
|
|
37
|
Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters.
|
Am J Hematol
|
2014
|
0.81
|
|
38
|
CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner.
|
Am J Clin Pathol
|
2007
|
0.81
|
|
39
|
Molecular diagnosis of acute myeloid leukemia.
|
Expert Rev Mol Diagn
|
2010
|
0.81
|
|
40
|
CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry.
|
Hum Pathol
|
2005
|
0.80
|
|
41
|
A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
|
Cancer Genet Cytogenet
|
2007
|
0.79
|
|
42
|
Expanded populations of surface membrane immunoglobulin light chain-negative B cells in lymph nodes are not always indicative of B-cell lymphoma.
|
Am J Clin Pathol
|
2005
|
0.79
|
|
43
|
Genetics of diffuse large B-cell lymphoma: paving a path to personalized medicine.
|
Cancer J
|
2014
|
0.79
|
|
44
|
Molecular diagnostics of acute myeloid leukemia: it's a (next) generational thing.
|
J Mol Diagn
|
2012
|
0.79
|
|
45
|
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
|
Cancer Biol Ther
|
2007
|
0.79
|
|
46
|
The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights.
|
Hematology
|
2006
|
0.79
|
|
47
|
Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies.
|
J Mol Diagn
|
2008
|
0.78
|
|
48
|
Minimal residual disease testing to predict relapse following transplant for AML and high-grade myelodysplastic syndromes.
|
Expert Rev Mol Diagn
|
2011
|
0.78
|
|
49
|
ZAP70 expression assessed by immunohistochemistry on peripheral blood: a simple prognostic assay for patients with chronic lymphocytic leukemia.
|
Appl Immunohistochem Mol Morphol
|
2007
|
0.77
|
|
50
|
Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies.
|
Clin Lab Med
|
2011
|
0.77
|
|
51
|
Molecular genetic characterization of lymphoma: application to cytology diagnosis.
|
Diagn Cytopathol
|
2012
|
0.77
|
|
52
|
Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.
|
Expert Rev Mol Diagn
|
2007
|
0.77
|
|
53
|
BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.
|
Blood
|
2013
|
0.76
|
|
54
|
Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3-, natural killer (NK)-like cytotoxic T-cell lymphoma.
|
Am J Surg Pathol
|
2002
|
0.76
|
|
55
|
Posttransplantation lymphoproliferative disease involving the pituitary gland.
|
Hum Pathol
|
2010
|
0.76
|
|
56
|
Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors.
|
Adv Anat Pathol
|
2014
|
0.76
|
|
57
|
An alternative spliced RNASEL variant in peripheral blood leukocytes.
|
J Interferon Cytokine Res
|
2006
|
0.76
|
|
58
|
Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
|
Appl Immunohistochem Mol Morphol
|
2010
|
0.76
|
|
59
|
Multiple cutaneous monoclonal B-cell proliferations as harbingers of systemic angioimmunoblastic T-cell lymphoma.
|
J Cutan Pathol
|
2009
|
0.76
|
|
60
|
T cell receptor gamma-chain gene polymerase chain reaction to diagnose central nervous system involvement by cutaneous T cell lymphoma.
|
J Mol Diagn
|
2002
|
0.75
|
|
61
|
Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
|
Am J Hematol
|
2007
|
0.75
|
|
62
|
Making a meal of multiple mutations in acute myeloid malignancies.
|
J Mol Diagn
|
2011
|
0.75
|
|
63
|
α-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors.
|
Am J Surg Pathol
|
2012
|
0.75
|
|
64
|
The role of molecular pathology in the diagnosis of cutaneous lymphomas.
|
Patholog Res Int
|
2012
|
0.75
|
|
65
|
Transient blood transfusion reaction masquerading as a post-transplantation lymphoproliferative disorder mimicking acute leukemia cutis.
|
J Clin Oncol
|
2011
|
0.75
|
|
66
|
Toward a therapeutically relevant, molecularly based classification of lymphoma: are we there yet?
|
Am J Clin Pathol
|
2007
|
0.75
|
|
67
|
A 2020 Vision Into Hodgkin Lymphoma Biology.
|
Adv Anat Pathol
|
2020
|
0.75
|
|
68
|
Large B-cell lymphoma masquerading as acute leukemia.
|
J Clin Oncol
|
2006
|
0.75
|
|
69
|
Hereditary elliptocytosis.
|
Blood
|
2013
|
0.75
|
|
70
|
The basis and rational use of molecular genetic testing in mature B-cell lymphomas.
|
Adv Anat Pathol
|
2010
|
0.75
|
|
71
|
Images Dx. Severe babesiosis.
|
J Hosp Med
|
2010
|
0.75
|
|
72
|
Crystal-storing histiocytosis in plasma cell myeloma.
|
Am J Hematol
|
2010
|
0.75
|
|
73
|
Diagnostic challenges in the myelodysplastic syndromes: the current and future role of genetic and immunophenotypic studies.
|
Expert Opin Med Diagn
|
2009
|
0.75
|
|
74
|
Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosis.
|
J Clin Oncol
|
2002
|
0.75
|
|
75
|
Coexistent BCR-ABL1 and JAK2 V617F: converting CML dwarves to ET staghorns with imatinib therapy.
|
Blood
|
2014
|
0.75
|
|
76
|
Reactive versus neoplastic lymphoid follicles: proliferation and death versus quiescence and staying alive.
|
Br J Haematol
|
2004
|
0.75
|
|
77
|
Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene.
|
Leuk Lymphoma
|
2011
|
0.75
|